Nucleus Network, Australia and USA’s Premier Phase I Specialists
Nucleus Network is the only Phase I clinical trial specialist with phase I units in both Australia and the United States. We have three units with 220+ beds and conduct a broad range of early phase clinical trials including FIH, DDI, TQT, Vaccine, Renal/Hepatic Impairment and Biosimilars.
The Australian clinical trial landscape allows global biotechs to advance their early phase clinical programs faster (Rapid Review cycles), easier (No IND), cheaper (43.5% Tax Incentive) and to the same quality standard (ICH/GCP) as studies performed in the USA.
We are Australia’s largest Phase I clinical trial provider with two clinics located in the major Australian cities of Melbourne and Brisbane enabling access to >50% (multiples more than any other Phase I group) of the population. Our large molecule Center of Excellence in Brisbane has been dedicated to development of New Biological Entities, Biosimilars and Vaccines for more than 20 years. This specialization leads to better recruitment outcomes for our sponsors and their programs.Our US clinic resides in the biotech hub of Minneapolis, Minnesota enabling us access to a total of more than 18 million people across all three sites.
Operating in the two global regions where a majority of Phase I studies are performed allows our sponsors to exceed their Phase I value inflection targets rapidly, efficiently and meet international quality standards allowing progression into Phase 2 and beyond.